Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012;11(1):25-7.

Amyotrophic lateral sclerosis with laboratory abnormalities of uncertain significance: A brief review

Majid Ghasemi  1 , Farzad Fatehi, Bahador Asadi, Fariborz Khorvash
Affiliations
Review

Amyotrophic lateral sclerosis with laboratory abnormalities of uncertain significance: A brief review

Majid Ghasemi et al. Iran J Neurol. 2012.

Abstract

Amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease, is a progressive and devastating disease involving both lower and upper motor neurons, typically following a relentless progression towards death. Therefore, all efforts must be made by the clinician to exclude alternative and more treatable entities. ALS with laboratory abnormalities of uncertain significance is a subgroup of ALS that occurs in association with laboratory defined abnormalities that are of uncertain significance to the pathogenesis of ALS. The clinical utility of these abnormalities and what they ultimately mean in patients with ALS is discussed here, along with a review of the literature.

Keywords: Amyotrophic Lateral Sclerosis; Laboratory Abnormality; Motor Neuron Disease.

PubMed Disclaimer

References

    1. Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90. - PMC - PubMed
    1. Forbes RB, Colville S, Parratt J, et al. The incidence of motor nueron disease in Scotland. J Neurol. 2007;254:866–9. - PubMed
    1. O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateralsclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2. - PubMed
    1. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J. Neurol. Sci. 1994;1(124) Suppl:96–107. - PubMed
    1. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9. - PubMed

LinkOut - more resources